Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in GALT — Galectin Therapeutics Inc

CIK 70858 CHARLOTTE, NC
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$267,797
+$117,523 QoQ
Shares Held
57,715
+7.2% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. GALT ranks #272 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in GALT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $267,797 57,715
2026-03-31 $150,274 53,862
2025-12-31 $104,261 25,063
2025-09-30 $107,386 25,327
2025-06-30 $23,297 11,042
2025-03-31 $18,064 14,808
2024-12-31 $49,480 38,358
2024-09-30 $52,364 19,042
2024-06-30 $41,484 18,356
2024-03-31 $35,210 14,733
2023-12-31 $9,348 5,632
2023-09-30 $10,761 5,605
2023-06-30 $8,070 5,605
2023-03-31 $11,770 5,605
2022-12-31 $6,717 5,945
2022-09-30 $9,692 5,947
2022-06-30 $10,213 7,797
2022-03-31 $15,450 9,597
2021-12-31 $13,563 6,553
2021-09-30 $21,403 5,517
2021-06-30 $39,093 12,217
2021-03-31 $103,340 47,623
2020-12-31 $24,170 10,791
2020-09-30 $20,092 7,526
2020-06-30 $33,338 10,895
2020-03-31 $8,686 4,433